MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

Search

Microbot Medical Inc

Cerrado

2.5 -2.72

Resumen

Variación precio

24h

Actual

Mínimo

2.45

Máximo

2.57

Métricas clave

By Trading Economics

Ingresos

791K

-2.6M

BPA

-0.08

Empleados

20

EBITDA

-127K

-3.4M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+246.15% upside

Dividendos

By Dow Jones

Próximas Ganancias

12 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

2.9M

95M

Apertura anterior

5.22

Cierre anterior

2.5

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

Microbot Medical Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 jul 2025, 15:29 UTC

Principales Movimientos del Mercado

Mustang Bio Shares Jump After Orphan Drug Designation for Cancer Treatment

7 jul 2025, 23:44 UTC

Charlas de Mercado

Nikkei May Fall on U.S. Tariff Concerns -- Market Talk

7 jul 2025, 23:44 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 jul 2025, 23:41 UTC

Charlas de Mercado

Gold Edges Lower Amid Hopes for Possible Trade Agreements -- Market Talk

7 jul 2025, 23:19 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

7 jul 2025, 23:19 UTC

Charlas de Mercado

AML3D Bull Sees Navy Letter Lowering Risks -- Market Talk

7 jul 2025, 22:20 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

7 jul 2025, 22:20 UTC

Charlas de Mercado

AT&T's Fiber Strategy Positions Stock to Outperform -- Market Talk

7 jul 2025, 21:34 UTC

Adquisiciones, fusiones, absorciones

BlackRock's Latest Acquisition Is a Commercial Real Estate Bet -- Barrons.com

7 jul 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

7 jul 2025, 20:45 UTC

Adquisiciones, fusiones, absorciones

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7 jul 2025, 20:16 UTC

Charlas de Mercado

Canada Bonds Set to Benefit From Rotation Away U.S. Assets -- Market Talk

7 jul 2025, 19:37 UTC

Charlas de Mercado

U.S. Natural Gas Futures Hold Their Ground -- Market Talk

7 jul 2025, 19:12 UTC

Charlas de Mercado

Oil Futures Shrug Off Bigger OPEC+ Output Increase -- Market Talk

7 jul 2025, 18:33 UTC

Charlas de Mercado

Gold Flat as Investors Assess Market Direction -- Market Talk

7 jul 2025, 18:27 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 jul 2025, 16:53 UTC

Ganancias

Freight Stocks Have a Tariff Overhang. Morgan Stanley Says It Could Be Worse. -- Barrons.com

7 jul 2025, 16:30 UTC

Charlas de Mercado

Higher Prices Limit Power Sector's Natural Gas Use -- Market Talk

7 jul 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

7 jul 2025, 16:05 UTC

Adquisiciones, fusiones, absorciones

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7 jul 2025, 15:41 UTC

Charlas de Mercado

Gold Futures Fall as Stronger U.S. Dollar Undermines Safe-Haven Demand -- Market Talk

7 jul 2025, 15:41 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

7 jul 2025, 15:40 UTC

Charlas de Mercado

Base Metal Prices Tick Lower on U.S. Dollar Strength -- Market Talk

7 jul 2025, 15:30 UTC

Charlas de Mercado

Physical Oil Market Stable But Structural Weakness Looms -- Market Talk

7 jul 2025, 15:18 UTC

Charlas de Mercado

BNP Cuts Brent Forecast on U.S. Shale, Iran Supply Resilience -- Market Talk

7 jul 2025, 15:14 UTC

Adquisiciones, fusiones, absorciones

MicroStrategy Goes a Week Without Buying Bitcoin. Saylor Has Advice for Crypto Traders. -- Barrons.com

7 jul 2025, 15:00 UTC

Adquisiciones, fusiones, absorciones

GSK Completes Acquisition of Efimosfermin

7 jul 2025, 14:52 UTC

Charlas de Mercado

Dollar Faces Downward Pressures Stemming from Tariffs -- Market Talk

7 jul 2025, 14:51 UTC

Charlas de Mercado

Bullish Factors Lift Oil Despite Downward Pressure -- Market Talk

7 jul 2025, 14:45 UTC

Charlas de Mercado

Saudi Arabia Not Seeking to Take Oil Market Share -- Market Talk

Comparación entre iguales

Cambio de precio

Microbot Medical Inc previsión

Precio Objetivo

By TipRanks

246.15% repunte

Estimación a 12 Meses

Media 9 USD  246.15%

Máximo 9 USD

Mínimo 9 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Microbot Medical Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

1

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

2.52 / 2.57Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Very Strong Bullish Evidence

Largo Plazo

Weak Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.